Question 1

What is Henry Schein's P/E ratio?

Accepted Answer

Henry Schein (HSIC) P/E ratio is 24.9× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month earnings (net income), using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/E ratio calculated?

Accepted Answer

P/E = Share Price ÷ Trailing Twelve-Month (TTM) Diluted EPS, or equivalently Market Capitalisation ÷ TTM Net Income. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/E ratio?

Accepted Answer

The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.

Question 4

What is a good P/E ratio for Henry Schein?

Accepted Answer

There is no universal "good" P/E. As a rule of thumb, the S&P 500 has historically averaged a P/E in the mid-to-high teens; mature, slow-growth businesses commonly trade in the 10–18× range, while high-growth or asset-light companies often trade at 25–50×+. What matters is the comparison to sector peers and to the company's own historical range. For Henry Schein specifically, the relevant sector benchmark is the current sector median of 24.2×.

Question 5

Is Henry Schein's P/E ratio high or low?

Accepted Answer

Henry Schein's P/E ratio of 24.9× is above its own 5-year average of 21.0× and above the sector median of 24.2×. That places the current reading at the 88th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Henry Schein's historical P/E ratio range?

Accepted Answer

In the available daily series, Henry Schein (HSIC) P/E ratio has ranged from a low of 10.6× in 2008 to a high of 33.1× in 2025. The 5-year average is 21.0× and the 5-year median is 21.4×.

Question 7

What was Henry Schein's P/E ratio in 2025?

Accepted Answer

Henry Schein (HSIC) P/E ratio at the end of 2025 was 22.4×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month earnings figure available at that date.

Question 8

Why does Henry Schein's P/E ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (earnings). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$8.93B	$398M	22.4×	+0.4×	Dec 27, 2025
2024	$8.62B	$390M	22.1×	-1.5×	Dec 31, 2024
2023	$9.83B	$416M	23.6×	+3.7×	Dec 31, 2023
2022	$10.7B	$538M	19.9×	+2.7×	Dec 31, 2022
2021	$10.7B	$624M	17.2×	-6.5×	Dec 31, 2021
2020	$9.52B	$402M	23.7×	+4.6×	Dec 31, 2020
2019	$9.7B	$508M	19.1×	+1.7×	Dec 31, 2019
2018	$9.35B	$536M	17.4×	-4.0×	Dec 31, 2018
2017	$8.69B	$406M	21.4×	+2.7×	Dec 31, 2017
2016	$9.46B	$507M	18.7×	-2.6×	Dec 31, 2016
2015	$10.2B	$479M	21.3×	+2.2×	Dec 31, 2015
2014	$8.92B	$466M	19.1×	+1.5×	Dec 31, 2014
2013	$7.62B	$432M	17.7×	+3.6×	Dec 31, 2013
2012	$5.46B	$388M	14.1×	+1.9×	Dec 31, 2012
2011	$4.49B	$368M	12.2×	-1.2×	Dec 31, 2011
2010	$4.36B	$326M	13.4×	+1.6×	Dec 31, 2010
2009	$3.67B	$311M	11.8×	+1.2×	Dec 31, 2009
2008	$2.55B	$240M	10.6×	-9.3×	Dec 31, 2008
2007	$4.29B	$215M	19.9×	-0.8×	Dec 31, 2007
2006	$3.39B	$164M	20.7×	-0.0×	Dec 31, 2006
2005	$2.98B	$144M	20.8×	+2.2×	Dec 31, 2005
2004	$2.37B	$128M	18.5×	+1.6×	Dec 31, 2004
2003	$2.32B	$138M	16.9×	+3.7×	Dec 31, 2003
2002	$1.55B	$118M	13.2×	—	Dec 31, 2002


Agilent Technologies (A)	23.1×
Medtronic (MDT)	22.2×
McKesson (MCK)	22.2×
Illumina (ILMN)	21.7×
ResMed (RMD)	21.6×
GE HealthCare (GEHC)	21.6×
Pfizer (PFE)	21.1×
Quest Diagnostics (DGX)	21.1×
AptarGroup (ATR)	20.9×
IQVIA (IQV)	20.7×
Biogen (BIIB)	19.7×
Zoetis (ZTS)	18.9×
Gilead Sciences (GILD)	18.8×
Humana (HUM)	18.5×
Regeneron Pharmaceuticals (REGN)	18.2×
Bristol-Myers Squibb (BMY)	17.0×
Elevance Health (ELV)	17.0×
HCA Healthcare (HCA)	15.8×
AstraZeneca (AZN)	14.7×
DaVita (DVA)	13.3×
Incyte (INCY)	13.1×
Cigna (CI)	11.1×
Novo Nordisk (NVO)	8.6×
Solventum (SOLV)	7.9×
Universal Health Services (UHS)	7.2×

P/E Ratio for Henry Schein (HSIC) 2002-2026

P/E Ratio daily chart for Henry Schein (HSIC)

Historical P/E Ratio for Henry Schein (HSIC) from 2002 to 2025

About P/E Ratio at Henry Schein (HSIC)

Henry Schein P/E Ratio by Year

Henry Schein P/E Ratio 2025: 22.4×

Henry Schein P/E Ratio 2024: 22.1×

Henry Schein P/E Ratio 2023: 23.6×

Henry Schein P/E Ratio 2022: 19.9×

Henry Schein P/E Ratio 2021: 17.2×

Sector peers by P/E Ratio — chart

Sector peers by P/E Ratio — table

Frequently asked questions

Henry Schein (HSIC) Key Financials